2021. Long-term safety and disease control with ruxolitinib cream among patients with atopic dermatitis based on previous medication history: Pooled results from two phase 3 studies. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s65. DOI:https://doi.org/10.25251/skin.5.supp.65.